• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Introduction to (2S)-2-(Phenoxymethyl)morpholine Hydrochloride (CAS No. 661470-52-6)

(2S)-2-(Phenoxymethyl)morpholine hydrochloride, with the chemical identifier CAS No. 661470-52-6, is a compound of significant interest in the field of pharmaceutical research and development. This compound, belonging to the morpholine class, has garnered attention due to its potential applications in medicinal chemistry and drug design. The unique structural features of this molecule, particularly its stereochemistry and functional groups, make it a valuable candidate for further exploration in various therapeutic areas.

The< strong>phenoxymethyl moiety in the molecular structure of (2S)-2-(phenoxymethyl)morpholine hydrochloride introduces a hydrophobic aromatic ring connected to a morpholine backbone. This configuration suggests potential interactions with biological targets, making it an attractive scaffold for developing novel pharmacological agents. The< strong>hydrochloride salt form enhances the solubility and stability of the compound, facilitating its use in both in vitro and in vivo studies.

In recent years, there has been growing interest in the development of chiral drugs due to their improved efficacy and reduced side effects compared to their racemic counterparts. The stereochemistry of (2S)-2-(phenoxymethyl)morpholine hydrochloride, specifically the (2S) configuration, is crucial for its pharmacological properties. Research has shown that enantiomeric purity significantly influences the biological activity of morpholine derivatives. The precise stereochemical control achieved in this compound makes it a promising candidate for further investigation.

The< strong>morpholine ring is a common pharmacophore found in many bioactive molecules. Its ability to form hydrogen bonds and interact with various biological targets makes it a versatile scaffold for drug design. Additionally, the< strong>phenoxymethyl group can contribute to the compound's binding affinity by engaging in hydrophobic interactions and π-stacking with biological receptors. These features collectively enhance the potential of (2S)-2-(phenoxymethyl)morpholine hydrochloride as a lead compound for therapeutic applications.

Recent studies have highlighted the importance of understanding the molecular interactions between small molecules and biological targets at an atomic level. Computational methods such as molecular dynamics simulations and quantum mechanical calculations have been instrumental in elucidating these interactions. In the case of (2S)-2-(phenoxymethyl)morpholine hydrochloride, computational studies have revealed that its binding mode to target proteins is influenced by both its stereochemistry and functional groups. These insights have guided the optimization of the compound's structure to improve its pharmacological properties.

The< strong>CAS No. 661470-52-6 registry number ensures that researchers can reliably identify and procure this compound for their studies. The availability of high-quality synthetic materials with well-documented specifications is crucial for conducting rigorous pharmaceutical research. (2S)-2-(Phenoxymethyl)morpholine hydrochloride, being a well-characterized compound, serves as a valuable tool for academic and industrial researchers alike.

In conclusion, (2S)-2-(phenoxymethyl)morpholine hydrochloride represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential therapeutic applications. The combination of stereochemical precision, functional group diversity, and computational insights makes this compound a promising candidate for further development. As research continues to uncover new biological targets and mechanisms, compounds like (2S)-2-(phenoxymethyl)morpholine hydrochloride will play an increasingly important role in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)